ArticleMultiple sclerosis journal - experimental, translational and clinical

Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis.

John Kramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.